Clinical Trials Logo

Clinical Trial Summary

Aim: In this project proposition the investigators would like to examine the effect of immune modulation by probiotics on the clearance of HPV-infections. This study provides a model for viral infection but also for cancer precursors. This would be an excellent model (and the only possible short-term model) to examine an effect on cancer precursors. Cancer precursors (cytological abnormalities such as L-SIL) are a scientifically accepted surrogate endpoint for cervical cancer, for example in HPV-vaccine studies. Research question: Does daily intake of probiotics lead to a better immune-response in HPV-infected women, i.e. does it facilitate clearance of the virus and/or regression of cytological lesions?


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01097356
Study type Interventional
Source Universiteit Antwerpen
Contact
Status Completed
Phase N/A
Start date April 2010
Completion date December 2011